AP
Alkermes Plc
🇺🇸XNAS.ALKSUnited StatesHealthcare
$46.08USDup +0.02 (+0.04%)ClosedDelayed2:37 AM
Price$46.08+0.02 (+0.04%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- USG017671052
- CUSIP
- 01642T108
Company
- Employees
- 2,050
- Headquarters
- Dublin, United States
- Website
- https://www.alkermes.com
- CEO
- Mr. Blair C. Jackson
Market
- Shares outstanding
- 167.8M
- Market cap
- $7.73B
Key dates
- Next earnings
- Oct 27, 2026
Highlights
- Market cap
- $7.73B
- EPS LTM
- $0.40
- P/E LTM
- 131.43
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.67B+10.79%up year on year
- Net income
- $66.12M-81.02%down year on year
- Gross margin
- 84.56%-0.67%down year on year
- Free cash flow
- $221.65M-53.81%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.